Chemotherapy of colorectal cancer

Δείτε το αρχείο  
Φορέας Ελληνική Γαστροεντερολογική Εταιρία
Συλλογή Annals of Gastroenterology Chemotherapy of colorectal cancer
Επιμέρους συλλογή Special Topics
ΠεριγραφήSUMMARY Approximately 75% of all patients with colorectal carcinoma will present at a stage when all gross carcinoma can be surgically resected. Despite the high resectability rate, half of all patients with colorectal adenocarcinoma die from metastatic disease, primarily because of residual disease that is not apparent at the time of surgery. These patients are candidates for adjuvant local or systemic therapies. Systmemic chemotherapy is the treatment of choice as well as for patients with recurrent or metastatic disease.
Δημιουργός M. Vassilomanolakis, G. Koumakis,
ΕκδότηςAnnals of Gastroenterology
ΠηγήAnnals of Gastroenterology; Volume 16, No 3 (2003)